Copyright
©The Author(s) 2024.
World J Methodol. Mar 20, 2024; 14(1): 89196
Published online Mar 20, 2024. doi: 10.5662/wjm.v14.i1.89196
Published online Mar 20, 2024. doi: 10.5662/wjm.v14.i1.89196
Table 1 Definitions related to gut microbiome and its action
Terminology | Significance |
Microbiota | All microorganisms living in the gut |
Microbioma | Sum of microbes, their genetic information, and their ecological niche |
Metagenome | Total genes providing information on genetic potential |
Indigenous microbiota | Resident gut microbiota in the healthy subjects |
Dysbiosis | Modification of the composition of gut microbiota causing diseases |
Pathobionts | Gut microbiota causing diseases |
Table 2 Distribution of normal gut flora in different parts of intestine
Intestine sections | Function | Normal flora |
Stomach | Acid production, pepsin, amylase, CFU < 103/mL | Lactobacillus; Streptococcus; Helicobacter pylori |
Small intestine: Duodenum, jejunum | Pancreatic enzymes, bicarbonate ions, bile salts, CFU: 103-104/mL | Lactobacilli; Enterococci, Streptococci; Actinobacteria |
Small intestine: Ileum | CFU: 103-109/mL | Enterococcus; Bacteroidetes; Lactobacillus; Clostridium; Corynebacteria |
Large intestine: Cecum, colon | Mucus and bicarbonate; CFU: 1010-1012/mL | Bacteroidetes; Clostridium; Eubacterium; Ruminococcus; Streptococcus; Enterococcus; Lactobacillus; Fusobacteria |
Table 3 Metabolites produced by gut microbiota and their functions
Metabolites | Functions | Ref. |
Bile acid metabolites; including deoxycholic acid and lithocholic acid | Regulate bile acid, cholesterol, lipid, glucose, and activate host nuclear receptors and cell signaling pathways | Ramírez-Macías et al[39] |
Short-chain fatty acids metabolites | Regulate food intake and insulin secretion, also aid in maintaining body weight | Psichas et al[40] |
Branched-chain fatty acids including isobutyrate | Histone deacetylase inhibition, increased histone acetylation | Mischke et al[41] |
Indole derivatives including indoxyl sulfate and IPA | IPA exhibits neuroprotective effects, acts as a powerful antioxidant and regulates intestinal barrier function | Hendrikx et al[42] |
Lipopolysaccharide, peptidoglycan, lipoteicholic acid | Epigenetic regulation of genes in colorectal cancer, modulation of chromatine structure and transcriptional activity | Lightfoot et al[43] |
Phenolic derivatives include 4-OH phenylacetic acid, urolithins, enterodiol and 9-prenylaringenin | Exhibit antimicrobial effect, maintain intestinal health and protect against oxidative stress | Larrosa et al[44] |
Choline metabolites include choline, trimethylamine N-oxide, and betaine | Regulating lipid metabolism, and glucose synthesis contribute to the development of cardiovascular disease | Smallwood et al[45] |
Polyamines include putrescine, spermidine and spermine | Sustaining the high proliferation rate of intestinal epithelial cells enhances intestinal barrier integrity and enhances the systematic adaptive immune system | Rooks et al[46] |
Vitamins including thiamine (B1), riboflavin (B2), niacin (B3), pyridoxine (B6) panthotenic acid (B5), biotin (B7), folate (B11, B9), cobalamin (B12), and menaquinone (K2) | Help in red blood cell formation, DNA replication, and repair, work as an enzymatic co-factor, and enhance immune functioning | Nicholson et al[47] |
Ethanol | Protein fermentation metabolism may be involved in NAFLD progression | Yao et al[48] |
Hydrogen sulfide | Reduction/neutralization of reactive oxygen species | Afanas'ev et al[49] |
Table 4 Examples of gut microbiota-derived metabolites and their beneficial effects on human health
Metabolite | Pathway | Microbial agent | Health benefits |
Butyrate | Carbohydrate metabolism | Clostridia; Faecalibacterium prausnitzii; Coprococcus catus; Anaerostipes hadrus | Increased intestinal barrier function; Modulate intestinal macrophage function; Suppression of colonic inflammation; Improvements in insulin sensitivity |
Propionate | Carbohydrate metabolism | Blautia obeum; Coprococcus catus; Roseburia inulinivorans; Prevotella copri | Suppression of colonic inflammation; Decreased innate immune response to microbial stimulation; Protection from allergic airway inflammation; Improvements in insulin sensitivity and weight control in obese mice |
Indole | Tryptophan metabolism | Lactobacillus; Bifinobacterium longum; Bacteroides fragilis | Maintenance of host-microbe homeostasis at mucosal surfaces via IL-22; Increased barrier function; Modulation of host metabolism |
Indole-3-aldehyde | Tryptophan metabolism | Lactobacillus | Maintenance of mucosal homeostasis and intestinal barrier function via increased IL-22 production; Protection against intestinal inflammation in mouse models of colitis |
Indole-3-propionate | Tryptophan metabolism | Clostridium sporogenes | Maintenance of intestinal barrier function and mucosal homeostasis; Increased production of antioxidant and neuroprotectant products |
10-hydroxy-cis-12-octadecoate | Linoleic acid derivative (lipid metabolism) | Lactobacillus | Maintenance of intestinal barrier function; Decreased inflammation; Increased intestinal IgA production |
Table 5 Some examples of potentially harmful gut microbiota bacterial species
Bacteria | Associated physiologic changes | Associated diseases states |
Bacteroides | Activate CD4+ T cells | Increased with animal-based diet; Increased in obesity |
Bilophila | Promote pro-inflammatory immunity | Increased in colitis; Decreased in autism |
Clostridium | Promote generation Th17 cells | Increased after smoke exposure; Increased in autism and Rett syndrome; Positive correlation with plasma insulin and weight gain; Increased in type 2 diabetes; Clostridium perfrigens increased in old age |
Escherichia coli | TLR activation | Increased in inflammatory bowel disease; Increased in type 2 diabetes |
Neisseria | Sugar fermentation | Only two species are pathogenic: Neisseria meningitides and Neisseria gonorrhoeae |
Table 6 Diseases associated with gut microbiota abnormalities
Disease | Features |
Irritable bowel syndrome | An abundance of Firmicutes and a decrease of Bacteroidetes |
Type I diabetes | In genetically predisposed individuals, autoimmune against pancreatic β-cells. Deficient development or alteration of the microbiota may contribute to dysfunctional immunity with the devastation of autoimmune β-cells and increased leakiness of the intestinal barrier. Variability of microbiomes reduced |
Asthma | Outbreaks of Chlamidophila pneumonia during bronchitis and pneumonia development affect the airway microbiome. Gut microbiota is influenced by the introduction of microbiota to the environment, particularly in early life, which helps immune function growth and the development of defending against allergic sensitization |
Food-borne pathogens and food poisoning | Opportunistic pathogens (Campylobacter, Salmonella, Escherichia coli, Shigella) disturb the microbiome’s balance leading to dysbiosis |
Malnutrition | Decrease or missing species that either process food categories efficiently or produce vitamins may reduce the absorption of nutrients. An overabundance of Enetrobacteriaceae can lead to epithelial damage, diarrhea, and limited absorption of nutrients |
Depression | In physiologic system, Bifidobacterium infantis, generally found in infants’ gastrointestinal tract and administered probiotic drugs, can have antidepressant effects |
Anxiety | Oral administration of Campylobacter jejuni subclinical doses in murine models induced anxiety like behavior without stimulating immunity |
- Citation: Salvadori M, Rosso G. Update on the gut microbiome in health and diseases. World J Methodol 2024; 14(1): 89196
- URL: https://www.wjgnet.com/2222-0682/full/v14/i1/89196.htm
- DOI: https://dx.doi.org/10.5662/wjm.v14.i1.89196